Attached files
file | filename |
---|---|
8-K - FORM 8-K - AMSURG CORP | g21391e8vk.htm |
Exhibit 99.1
FOR IMMEDIATE RELEASE
|
Contact: | Claire M. Gulmi | ||
Executive Vice President and | ||||
Chief Financial Officer | ||||
(615) 665-1283 |
AMSURG NAMES JOHN W. POPP, JR., M.D. TO BOARD OF DIRECTORS
NASHVILLE, Tenn. (November 23, 2009) AmSurg Corp. (NASDAQ: AMSG), today announced the
appointment of John W. Popp, Jr., M.D. to its Board of Directors. Dr. Popp is Clinical Professor
of Medicine at the University of South Carolina School of Medicine and a Medical Director for
Centocor, Inc., a unit of Johnson and Johnson, which provides innovative biomedicines for
debilitating immune disorders. Dr. Popp is a board-certified internist and gastroenterologist.
Since 1998, he has served on the Board of Trustees for the American College of Gastroenterology and
is a past President of the College. Dr. Popp is a cum laude graduate of both Yale Medical School
and Vanderbilt University.
Christopher A. Holden, President and Chief Executive Officer of AmSurg, remarked, We are very
pleased to name such an eminent gastroenterologist as Dr. Popp to our Board of Directors.
Throughout his career, Dr. Popp has distinguished himself through his practice of medicine and
through his extensive research and publications. He brings a unique perspective as a physician to
our Board, and his appointment is a reflection of AmSurgs focus on continually enhancing the value
proposition we provide our physician partners and our ability to be their strategic partner of
choice. With Dr. Popps experience and leadership capabilities, we are confident he will
contribute to our achieving these goals and to the long-term growth of AmSurg.
AmSurg Corp. acquires, develops and operates ambulatory surgery centers in partnership with
physician practice groups throughout the United States. At September 30, 2009, AmSurg owned a
majority interest in 194 continuing centers in operation and had two centers under development.
-END-